HAS-BLED score: Difference between revisions
(New page: {{SI}} {{CMG}} ==Overview== A therapeutic bleeding risk stratification score for those on oral anticoagulants in atrial fibrillation<ref>[http://www.ncbi.nlm.nih.gov/sites/entrez...) |
No edit summary |
||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
{{EJ}} | |||
==Overview== | ==Overview== | ||
| Line 40: | Line 42: | ||
|----- | |----- | ||
|} | |} | ||
A score of 3 or more indicates increased one year bleed risk on anticoagulation sufficient to justify caution or more | |||
==Interpretation of the HAS-BLED Score== | |||
A score of 3 or more indicates an increased one year bleed risk on anticoagulation which would be sufficient to justify caution or more frequent evaluation. The risk is the risk of an intracranial bleed, bleeding requiring hospitalization or a hemoglobin drop <u>></u> 2g/L or a bleeding episode that requires transfusion. | |||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 19:16, 26 November 2010
|
WikiDoc Resources for HAS-BLED score |
|
Articles |
|---|
|
Most recent articles on HAS-BLED score Most cited articles on HAS-BLED score |
|
Media |
|
Powerpoint slides on HAS-BLED score |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on HAS-BLED score at Clinical Trials.gov Trial results on HAS-BLED score Clinical Trials on HAS-BLED score at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on HAS-BLED score NICE Guidance on HAS-BLED score
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on HAS-BLED score Discussion groups on HAS-BLED score Patient Handouts on HAS-BLED score Directions to Hospitals Treating HAS-BLED score Risk calculators and risk factors for HAS-BLED score
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for HAS-BLED score |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
A therapeutic bleeding risk stratification score for those on oral anticoagulants in atrial fibrillation[1]. It is matched to the CHA2DS2-VASc score used for stroke risk stratification but has not as of 2010 been externally validated.
| Feature | Score if present |
|---|---|
| Hypertension (Systolic ≥ 160mmHg) | 1 |
| Abnormal renal function | 1 |
| Abnormal liver function | 1 |
| Age ≥ 65 years | 1 |
| Stroke in past | 1 |
| Bleeding | 1 |
| Labile INRs | 1 |
| Taking other drugs as well | 1 |
| Alcohol intake at same time | 1 |
Interpretation of the HAS-BLED Score
A score of 3 or more indicates an increased one year bleed risk on anticoagulation which would be sufficient to justify caution or more frequent evaluation. The risk is the risk of an intracranial bleed, bleeding requiring hospitalization or a hemoglobin drop > 2g/L or a bleeding episode that requires transfusion.